Adulterants Testing
Kratom Adulterants
The Kratom Adulterants panel quantitatively reports six named targets associated with emerging kratom-market formulations and adulterant-screening questions.
Share the exact product, matrix, reporting objective, target market, and deadline. The laboratory confirms method-and-matrix fit, sample requirements, reporting basis, timing, and price during technical review.
For quote and submission: reference Test Code T191.
Six individually reported targets
Every analyte below is quantitatively reported. No broader class total is implied by this list.
- 017-Hydroxymitragynine
- 02Mitragynine pseudoindoxyl
- 039-Hydroxycorynantheidine
- 04Dihydro-7-hydroxymitragynine (MGM-15)
- 059-Fluoro-dihydro-7-hydroxymitragynine (MGM-16)
- 067-Acetoxymitragynine
Composition and adulterant targets are different scopes
The general Mitragyna Alkaloids profiles are intended for botanical potency and composition. The Kratom Adulterants panel keeps mitragynine pseudoindoxyl and other emerging derivative or adulterant targets in a separate analytical scope.
Each of the six listed targets is quantitatively reported. The panel does not establish botanical identity, determine whether a product is safe, provide legal advice, or certify regulatory compliance.
Compare the 5- and 11-analyte Mitragyna profilesFlorida Market Context
How this panel fits a Florida review
This six-target Kratom Adulterants panel is not a test method or panel mandated by Florida. Parent 7-hydroxymitragynine is one of its reported targets, but the current Florida ratio also needs a mitragynine result from an appropriate analytical scope.
For Florida review, 9-hydroxycorynantheidine is informational. It is not added to parent 7-OH, does not enter the 100:1 calculation, and does not determine label readiness. Scheduled substances are reviewed separately using the method's validated detection or identification limits; a not-detected result does not prove absolute absence.
The laboratory can review whether this panel, other analytical inputs, and the Florida-market reporting workflow fit a specific project. This website only collects the request; it does not perform analytical calculations, interpret results, or generate laboratory reports.
Read the current Florida updateRegulatory context reviewed August 26, 2026.
Operating details are confirmed for the submitted project
The public panel scope confirms the six quantitative targets. Method, matrix eligibility, sample quantity, reporting units, sensitivity, turnaround, accreditation applicability, and price are confirmed during technical review rather than assumed from another botanical method.
- Exact product and matrix
- Testing objective or customer-defined specification
- Target market or jurisdiction
- Requested reporting basis or units
- Required sensitivity or reporting limits
- Sample count and requested deadline
Planning a submission
Is this the same as the 11-analyte Mitragyna profile?
No. The 11-analyte profile is a general botanical potency and composition panel. Kratom Adulterants is a separate six-analyte testing scope that includes mitragynine pseudoindoxyl.
Does ordering this panel establish regulatory compliance?
No. The panel supplies quantitative analytical results for the six listed targets. It does not provide legal advice, determine safe use, or certify that a product complies with any jurisdiction's current requirements.
What sample quantity, reporting units, and turnaround apply?
Those operating details depend on the submitted matrix and project requirements and are confirmed during technical review before testing begins.